Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 21574 | 356 | 49.7 | 93% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 81 | 26583 | MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | LEUKEMIA STEM CELLS | Author keyword | 10 | 37% | 6% | 22 |
| 2 | EXPT THER EUT TRANSLAT ONCOL PROGRAM | Address | 8 | 35% | 5% | 18 |
| 3 | LEUKEMIC STEM CELL | Author keyword | 4 | 27% | 3% | 12 |
| 4 | IL ANIM | Address | 3 | 57% | 1% | 4 |
| 5 | LEUKEMIC STEM CELLS | Author keyword | 3 | 18% | 4% | 14 |
| 6 | LEUKAEMIC STEM CELL | Author keyword | 3 | 60% | 1% | 3 |
| 7 | CD123 | Author keyword | 2 | 19% | 3% | 11 |
| 8 | LEUKAEMIA STEM CELL | Author keyword | 2 | 67% | 1% | 2 |
| 9 | LEUKEMIC STEM CELL LSC | Author keyword | 2 | 67% | 1% | 2 |
| 10 | MARKEY CANC HEMATOL ONCOL | Address | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | LEUKEMIA STEM CELLS | 10 | 37% | 6% | 22 | Search LEUKEMIA+STEM+CELLS | Search LEUKEMIA+STEM+CELLS |
| 2 | LEUKEMIC STEM CELL | 4 | 27% | 3% | 12 | Search LEUKEMIC+STEM+CELL | Search LEUKEMIC+STEM+CELL |
| 3 | LEUKEMIC STEM CELLS | 3 | 18% | 4% | 14 | Search LEUKEMIC+STEM+CELLS | Search LEUKEMIC+STEM+CELLS |
| 4 | LEUKAEMIC STEM CELL | 3 | 60% | 1% | 3 | Search LEUKAEMIC+STEM+CELL | Search LEUKAEMIC+STEM+CELL |
| 5 | CD123 | 2 | 19% | 3% | 11 | Search CD123 | Search CD123 |
| 6 | LEUKAEMIA STEM CELL | 2 | 67% | 1% | 2 | Search LEUKAEMIA+STEM+CELL | Search LEUKAEMIA+STEM+CELL |
| 7 | LEUKEMIC STEM CELL LSC | 2 | 67% | 1% | 2 | Search LEUKEMIC+STEM+CELL+LSC | Search LEUKEMIC+STEM+CELL+LSC |
| 8 | TUMORAL REPROGRAMMING | 2 | 67% | 1% | 2 | Search TUMORAL+REPROGRAMMING | Search TUMORAL+REPROGRAMMING |
| 9 | CANCER MAINTAINING CELLS | 1 | 100% | 1% | 2 | Search CANCER+MAINTAINING+CELLS | Search CANCER+MAINTAINING+CELLS |
| 10 | CSC INHIBITORS | 1 | 100% | 1% | 2 | Search CSC+INHIBITORS | Search CSC+INHIBITORS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ABILITY IN VITRO | 37 | 55% | 13% | 47 |
| 2 | PRIMITIVE HEMATOPOIETIC CELL | 12 | 38% | 7% | 25 |
| 3 | LECTIN LIKE MOLECULE 1 | 6 | 100% | 1% | 4 |
| 4 | TOXIN INTERLEUKIN 3 FUSION PROTEIN | 4 | 38% | 2% | 8 |
| 5 | CYTOGENETICALLY ABERRANT CELLS | 3 | 60% | 1% | 3 |
| 6 | HEMATOPOIETIC CELL | 2 | 20% | 3% | 11 |
| 7 | AML STEM CELLS | 2 | 67% | 1% | 2 |
| 8 | CML STEM PROGENITOR CELLS | 2 | 67% | 1% | 2 |
| 9 | INTERLEUKIN 3 RECEPTOR | 2 | 19% | 3% | 10 |
| 10 | INTRAFEMORAL TRANSPLANTATION | 2 | 25% | 2% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Recent advances in acute myeloid leukemia stem cell biology | 2012 | 27 | 70 | 39% |
| Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials | 2014 | 4 | 98 | 40% |
| The variety of leukemic stem cells in myeloid malignancy | 2014 | 6 | 81 | 30% |
| Concise Review: Leukemia Stem Cells in Personalized Medicine | 2014 | 8 | 72 | 15% |
| Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells | 2011 | 43 | 63 | 29% |
| Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting | 2011 | 119 | 98 | 13% |
| Can immunotherapy specifically target acute myeloid leukemic stem cells? | 2013 | 9 | 79 | 32% |
| Relevance of leukemic stem cells in acute myeloid leukemia: heterogeneity and influence on disease monitoring, prognosis and treatment design | 2014 | 2 | 92 | 29% |
| Leukaemia stem cells and the evolution of cancer-stem-cell research | 2005 | 272 | 106 | 13% |
| Right on target: eradicating leukemic stem cells | 2007 | 57 | 91 | 25% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EXPT THER EUT TRANSLAT ONCOL PROGRAM | 8 | 35% | 5.1% | 18 |
| 2 | IL ANIM | 3 | 57% | 1.1% | 4 |
| 3 | MARKEY CANC HEMATOL ONCOL | 2 | 67% | 0.6% | 2 |
| 4 | UNIT HUMAN DIS MODELS | 2 | 36% | 1.1% | 4 |
| 5 | CHONGQING STEM CELL THER Y ENGN TECH | 1 | 50% | 0.6% | 2 |
| 6 | CELLULES SOUCHES HEMATOPOIET LEUCEM | 1 | 40% | 0.6% | 2 |
| 7 | AICF | 1 | 50% | 0.3% | 1 |
| 8 | CATEDRA SERV ONCOL MED | 1 | 50% | 0.3% | 1 |
| 9 | CHILD YOUTH CANC | 1 | 50% | 0.3% | 1 |
| 10 | COMPUTAT BIOL SUPPORT GRP | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000232753 | CANCER STEM CELLS//CD133//CANCER STEM CELL |
| 2 | 0.0000176557 | FLT3//FLT3 ITD//NPM1 |
| 3 | 0.0000141569 | HEMATOPOIETIC STEM CELL//SAKAGUCHI DEV BIOLSHINJUKU KU//SAKAGUCHI DEV BIOL |
| 4 | 0.0000131554 | HUMANIZED MICE//HU PBL SCID//SCID MOUSE |
| 5 | 0.0000101932 | MLL//MLL GENE//11Q23 |
| 6 | 0.0000099224 | ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML |
| 7 | 0.0000091765 | NUP98//T711P15P15//DDX10 |
| 8 | 0.0000086854 | LEUKEMIC BLAST PROGENITORS//L CFU//500 SHERBOURNE ST |
| 9 | 0.0000085534 | HEMATOGONES//BIPHENOTYPIC ACUTE LEUKEMIA//IMMUNOPHENOTYPING |
| 10 | 0.0000081038 | EX VIVO EXPANSION//CYTOKINE MEDIATED EXPANSION//AFT024 |